JP2024533420A5 - - Google Patents
Info
- Publication number
- JP2024533420A5 JP2024533420A5 JP2024515556A JP2024515556A JP2024533420A5 JP 2024533420 A5 JP2024533420 A5 JP 2024533420A5 JP 2024515556 A JP2024515556 A JP 2024515556A JP 2024515556 A JP2024515556 A JP 2024515556A JP 2024533420 A5 JP2024533420 A5 JP 2024533420A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- characteristic
- powder
- ray diffraction
- diffraction pattern
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111049581.4 | 2021-09-08 | ||
| CN202111049581.4A CN115772123A (zh) | 2021-09-08 | 2021-09-08 | 固体形式 |
| US202163243813P | 2021-09-14 | 2021-09-14 | |
| US63/243,813 | 2021-09-14 | ||
| PCT/US2022/042905 WO2023039063A1 (en) | 2021-09-08 | 2022-09-08 | Solid form of 5-(3,4-dichlorophenyl)-n-((1r,2r)-2-hydroxycyclohexyl)-6-(2,2,2-trifluoroethoxy)nicotinamide for use in treating kidney diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024533420A JP2024533420A (ja) | 2024-09-12 |
| JP2024533420A5 true JP2024533420A5 (https=) | 2025-09-12 |
Family
ID=83594511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515556A Pending JP2024533420A (ja) | 2021-09-08 | 2022-09-08 | 腎臓病の治療に用いられる５－（３，４－ジクロロフェニル）－ｎ－（（１ｒ，２ｒ）－２－ヒドロキシシクロヘキシル）－６－（２，２，２－トリフルオロエトキシ）ニコチンアミドの固形形態 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US11814354B2 (https=) |
| EP (1) | EP4399201A1 (https=) |
| JP (1) | JP2024533420A (https=) |
| AU (1) | AU2022342069A1 (https=) |
| CA (1) | CA3231117A1 (https=) |
| TW (1) | TW202334088A (https=) |
| WO (1) | WO2023039063A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11814354B2 (en) | 2021-09-08 | 2023-11-14 | River 3 Renal Corp. | Solid forms |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA107088C2 (xx) | 2009-09-11 | 2014-11-25 | 5-(3,4-дихлорфеніл)-n-(2-гідроксициклогексил)-6-(2,2,2-трифторетокси)нікотинамід і його солі як засоби, що підвищують концентрацію лвщ холестерину | |
| WO2012031817A1 (en) | 2010-09-09 | 2012-03-15 | F. Hoffmann-La Roche Ag | Determination of abca1 protein levels in cells |
| US20120101282A1 (en) | 2010-10-22 | 2012-04-26 | Pascal Dott | Process for the preparation of nicotinamide derivatives |
| WO2014180741A1 (en) | 2013-05-06 | 2014-11-13 | F. Hoffmann-La Roche Ag | Methods of identifying modulators of osbpl7 and the use of such modulators for treatment of diseases associated with osbpl7 |
| US20200085810A1 (en) * | 2018-07-26 | 2020-03-19 | Hoffmann-La Roche Inc. | Compounds for use in treating kidney disorders |
| US11814354B2 (en) | 2021-09-08 | 2023-11-14 | River 3 Renal Corp. | Solid forms |
-
2022
- 2022-09-07 US US17/939,203 patent/US11814354B2/en active Active
- 2022-09-08 AU AU2022342069A patent/AU2022342069A1/en active Pending
- 2022-09-08 EP EP22785823.0A patent/EP4399201A1/en active Pending
- 2022-09-08 JP JP2024515556A patent/JP2024533420A/ja active Pending
- 2022-09-08 WO PCT/US2022/042905 patent/WO2023039063A1/en not_active Ceased
- 2022-09-08 TW TW111134009A patent/TW202334088A/zh unknown
- 2022-09-08 CA CA3231117A patent/CA3231117A1/en active Pending
-
2023
- 2023-10-11 US US18/484,722 patent/US12134599B2/en active Active
-
2024
- 2024-09-27 US US18/898,885 patent/US20250263378A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025176008A5 (https=) | ||
| JP2023519891A5 (https=) | ||
| JP2024537795A5 (https=) | ||
| JP2023116503A5 (https=) | ||
| JP2020059759A5 (https=) | ||
| JP2021536511A5 (https=) | ||
| JP2010514807A5 (https=) | ||
| AU2007237818B2 (en) | A novel crystalline form of lamivudine | |
| JP2010511602A (ja) | １−（β−Ｄ−グルコピラノシル）−４−メチル−３−［５−（４−フルオロフェニル）−２−チエニルメチル］ベンゼン１／２水和物の結晶形 | |
| JP2023036708A5 (https=) | ||
| RU2009122241A (ru) | Твердые формы рацемического илапразола | |
| JP2012509321A5 (https=) | ||
| JP2012516344A5 (https=) | ||
| JP2024103495A5 (https=) | ||
| JP2025179094A5 (https=) | ||
| JP2022551525A5 (https=) | ||
| JP2024533420A5 (https=) | ||
| JP2023524518A5 (https=) | ||
| JP2024505063A5 (https=) | ||
| JP2022540922A5 (https=) | ||
| JP2022535850A5 (https=) | ||
| JPWO2021033729A5 (https=) | ||
| JP2023518399A5 (https=) | ||
| JP2016510767A5 (https=) | ||
| KR20080078804A (ko) | 이마티니브 메실레이트의 ｆ, ｇ, ｈ, ｉ 및 ｋ 결정형 |